Rencofilstat

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameRencofilstat
Drug Alias NameCyclosporine A analogue- Hepion PharmaceuticalsCRV-431CPI-43132
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclophilin B inhibitorsCyclophilin A inhibitorsCyclophilin D inhibitors
TargetsCyclophilin BCyclophilin ACyclophilin D
Therapy Area/IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoMexico +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesContravir Pharmaceuticals IncHepion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCiclofilin Pharmaceuticals IncPanetta Partners LtdFibrofind Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank